Insider Transactions in Q1 2024 at Poseida Therapeutics, Inc. (PSTX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2024
|
Johanna Mylet Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,091
-6.84%
|
$72,364
$4.13 P/Share
|
|
Mar 01
2024
|
Johanna Mylet Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,743
+23.4%
|
-
|
|
Mar 01
2024
|
Brent Warner President, Gene Therapy |
SELL
Payment of exercise price or tax liability
|
Direct |
35,739
-7.86%
|
$142,956
$4.13 P/Share
|
|
Mar 01
2024
|
Brent Warner President, Gene Therapy |
BUY
Grant, award, or other acquisition
|
Direct |
80,743
+15.08%
|
-
|
|
Mar 01
2024
|
Harry J Leonhardt GC & Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,306
-7.06%
|
$65,224
$4.13 P/Share
|
|
Mar 01
2024
|
Harry J Leonhardt GC & Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,743
+25.91%
|
-
|
|
Mar 01
2024
|
Mark J Gergen Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
34,157
-4.98%
|
$136,628
$4.13 P/Share
|
|
Feb 01
2024
|
Mark J Gergen Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
47,162
-6.44%
|
$141,486
$3.41 P/Share
|
|
Jan 02
2024
|
Mark J Gergen Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+14.58%
|
-
|
|
Jan 02
2024
|
Kristin Yarema President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+29.18%
|
-
|